Learn More
Medchemexpress LLC Blu2864 | 2810747-89-6 | 99.5% | 452.43 | 100 MG

Supplier: Medchemexpress LLC HY150076100MG
BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM for PRKACA. It exhibits anti-tumor activity and can be utilized in cancer and polycystic kidney disease research.
- Inhibits forskolin-induced in vitro cystogenesis
- Suppresses renal basal and total PKA activities
- Leads to higher urine outputs and lower kidney weights
- Reduces FLC tumor growth
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.